Safety and efficacy of elbasvir and grazoprevir in Japanese hemodialysis patients with genotype 1b hepatitis C virus infection
Goki Suda(Sapporo University), Hiroaki Haga(Yamagata University), Kazumichi Abe(Fukushima Medical University), Naoki Kawagishi(Hokkaido University), Naoya Sakamoto(Chibaken Saiseikai Narashino Hospital), Masatsugu Ohara(Hokkaido University), Yoshihito Uchida(Saitama Medical University), Hiromasa Ohira(Fukushima Medical University), Chitomi Hasebe(Japanese Red Cross Asahikawa Hospital), Masaru Baba(Hokkaido hospital), Mitsuteru Natsuizaka(Sapporo University), Masato Nakai(Hokkaido University), Ikuto Masakane(Yamagata University Hospital), Katsumi Terasita(Hokkaido hospital), Takuya Sho(Hokkaido University), Atsushi Takahashi(Fukushima Medical University), Satoshi Mochida(Saitama Medical University), Yoshiyuki Ueno(Yamagata Prefectural University of Health Sciences), Namiki Izumi(Musashino Red Cross Hospital), Koji Ogawa(The Japanese Society of Gastroenterological Surgery), Jun Itakura(Musashino Red Cross Hospital), Kenichi Morikawa(Hokkaido University), Masayuki Kurosaki(Musashino Red Cross Hospital), Ken Furuya(Hokkaido hospital), Machiko Umemura(Hokkaido University), Yoshiya Yamamoto, Masami Abe(University of Oxford), Tomoe Kobayashi(Shigei Medical Research Institute), Atsuhiko Kawakami, Kenichi Kumagai(Iwate Medical University)
Cited by 22
Related Papers
Clinical practice guidelines for hepatocellular carcinoma: The Japan Society of Hepatology 2017 (4th JSH‐HCC guidelines) 2019 update
|Hepatology Research|2019|539
An Overview of Regular Dialysis Treatment in Japan (As of 31 December 2013)
|Therapeutic Apheresis and Dialysis|2015|425
Evidence-based clinical practice guidelines for Liver Cirrhosis 2020
|Journal of Gastroenterology|2021|424
Meflin-Positive Cancer-Associated Fibroblasts Inhibit Pancreatic Carcinogenesis
|Cancer Research|2019|328